Arrowhead Stock Price on June 7, 2022 Breakdown


USD 33.05  0.23  0.69%   

As of today, the current price of Arrowhead Pharma is  33.05 , as last reported on the 3rd of October, with the highest price reaching  35.12  and the lowest price hitting  33.00  during the day.
Arrowhead Pharma secures Sharpe Ratio (or Efficiency) of -0.0584, which signifies that the company had -0.0584% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Arrowhead Pharma exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Arrowhead Pharma risk adjusted performance of 0.006, and Mean Deviation of 2.99 to double-check the risk estimate we provide.

Arrowhead Pharma Valuation on June 7, 2022

It is possible to determine the worth of Arrowhead Pharma on a given historical date. On June 7, 2022 Arrowhead was worth 32.39 at the beginning of the trading date compared to the closed value of 34.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arrowhead Pharma stock. Still, in general, we apply an absolute valuation method to find Arrowhead Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arrowhead Pharma's related companies.
 Open High Low Close Volume
  35.73    35.73    32.61    32.96    605,604  
  32.39    35.11    32.39    34.89    701,427  
  34.63    35.62    33.80    34.00    621,787  
Backtest Arrowhead Pharma  |  Arrowhead Pharma History  |  Arrowhead Pharma Valuation   PreviousNext  
Open Value 32.39
Closing Value

Arrowhead Pharma Trading Date Momentum on June 7, 2022

On June 08 2022 Arrowhead Pharma was traded for  34.00  at the closing time. The top price for the day was 35.62  and the lowest listed price was  33.80 . The trading volume for the day was 621.8 K. The trading history from June 8, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.55% . The overall trading delta against the current closing price is 18.69% .

Arrowhead Pharma Fundamentals Correlations and Trends

By evaluating Arrowhead Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arrowhead Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arrowhead financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Arrowhead Pharma Stock history

Arrowhead Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arrowhead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arrowhead Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arrowhead Pharma historical stock prices may prove useful in developing a viable investing in Arrowhead Pharma
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 329 people.

Arrowhead Pharma Stock Technical Analysis

Arrowhead Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arrowhead Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arrowhead Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Arrowhead Pharma Period Price Range

June 7, 2022





Arrowhead Pharma October 3, 2022 Market Strength

Market strength indicators help investors to evaluate how Arrowhead Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arrowhead Pharma shares will generate the highest return on investment. By undertsting and applying Arrowhead Pharma stock market strength indicators, traders can identify Arrowhead Pharma entry and exit signals to maximize returns

Arrowhead Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Arrowhead stock's direction in advance. Along with the technical and fundamental analysis of Arrowhead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arrowhead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please continue to Trending Equities. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
CEO Directory
Screen CEOs from public companies around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.